SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Marubeni Corporation (MARUY) trades at a trailing P/E of 0.1, forward P/E of 0.1. Trailing earnings yield is 769.23%, forward earnings yield 909.09%. PEG 0.02 (Peter Lynch undervalued ≤1.0).
Criteria proven by this page:
- VALUE (100/100, Pass) — P/E is below market average (0.1); PEG ≤ 1.0 — Peter Lynch undervalued (0.02); earnings yield beats bond yields (769.23%).
- Forward P/E 0.1 (down from trailing 0.1) — analysts expect earnings to grow, which would improve the valuation.
- PEG Ratio 0.02 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
- Trailing Earnings Yield 769.23% — exceeds typical bond yields (~4.3%), making equity attractive vs fixed income. Forward yield improves to 909.09% as earnings recover.
Overall SharesGrow Score: 64/100 with 2/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
100/100
Price-to-Earnings & upside
Proven by this page
~
HEALTH
50/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — MARUY
Valuation Multiples
P/E (TTM)0.1
Forward P/E0.1
PEG Ratio0.02
Forward PEG0.01
P/B Ratio0.00
P/S Ratio0.01
EV/EBITDA0.0
Per Share Data
EPS (TTM)$3,025.10
Forward EPS (Est.)$3,364.65
Book Value / Share$0.00
Revenue / Share$46,854.97
FCF / Share$0.00
Yields & Fair Value
Earnings Yield769.23%
Forward Earnings Yield909.09%
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$358.80 |
$7.3T |
$62.26B |
0.9% |
| 2017 |
$880.60 |
$7.13T |
$152.85B |
2.1% |
| 2018 |
$1,193.70 |
$7.54T |
$207.26B |
2.7% |
| 2019 |
$1,306.20 |
$7.4T |
$226.88B |
3.1% |
| 2020 |
$-1,160.30 |
$6.83T |
$-201.37B |
-2.9% |
| 2021 |
$1,261.70 |
$6.33T |
$223.26B |
3.5% |
| 2022 |
$2,424.40 |
$8.51T |
$424.32B |
5% |
| 2023 |
$3,155.80 |
$9.19T |
$543B |
5.9% |
| 2024 |
$2,798.00 |
$7.25T |
$471.41B |
6.5% |
| 2025 |
$3,025.10 |
$7.79T |
$502.97B |
6.5% |
